CORVUS PHARMACEUTICALS

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing ITK inhibition as a new approach to immunotherapy. Our mission is to bring cleverly-designed medicine to patients with difficult to treat cancers and immune diseases... We believe in putting patients first. With that in mind, we report our preclinical and clinical data promptly and frequently at major scientific meetings, so our research can be used by others to advance medicine for the benefit of patients.

Also known as: Corvus

Primary location: Burlingame United States